2nd NUVISAN DRUG DISCOVERY INNOVATION CHALLENGE
Orphan Diseases and Challenging Targets
Collaborate with venture capital and scientific experts for your drug discovery projects
1 Min
More 
Interview | Prof. Dr. Martin Gersch, Freie Universität Berlin School of Business & EconomicsDepartment of Information Systems, Professor of Business Administration, Health-X Innovation Hub
Connected, comprehensive and always available – the future of health data
6 Min
More Noah Labs receives €3 million in financing round lead by Nina Capital
Noah Labs, a Berlin and Potsdam-based digital health startup focused on AI-powered telemonitoring for patients with heart failure, has successfully closed a seed funding round of €3 million. Lead investor Nina Capital from Barcelona a dedicated…
3 Min
More Gut microbiome influences location of immune cells
Researchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité – Universitätsmedizin Berlin have found that microbial communities in the mouse GI tract are unevenly distributed, which influences immune cell…
3 Min
More Formo bags $61 million in Series B funding - launches the world’s first animal-free cheese made with Koji Protein
German food fermentation startup Formo has secured $61 million in Series B funding to scale its operations. The round includes existing investors, such as Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures and…
3 Min
More New regulator of glucose transport in adipose tissue discovered
The role of the adapter protein Picalm in the development of Alzheimer's disease is well known. Now, researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), the German Center for Diabetes Research (DZD), ETH Zurich, and…
3 Min
More On a mission to cure HIV: Christian Gaebler receives ERC Starting Grant
Prof. Christian Gaebler, an HIV researcher at Charité – Universitätsmedizin Berlin, has a goal: to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, even without…
4 Min
More Impressive results against autoimmune disease
Severe systemic lupus no longer detectable after cancer medication treatment
5 Min
More A new drug target for psychiatric disorders
Misha Kudryashev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. Published in “The EMBO Journal,” the study points to a potentially…
4 Min
More Berlin startup Lucid Genomics secures pre-seed funding of €1.3 million to fine-tune their AI models for diagnostics and biomarker identification
Lucid Genomics, a pioneering Berlin-based startup spin-off from the Max Planck Institute for Molecular Genetics and Charité - Universitätsmedizin Berlin, raised €1.3 million pre-seed funding round led by Caesar Ventures, with additional support from…
3 Min
More Show more items
